Jefferies assumes Sequenom (SQNM +0.7%) at Buy (price target $6) citing momentum for the...

|By:, SA News Editor

Jefferies assumes Sequenom (SQNM +0.7%) at Buy (price target $6) citing momentum for the company's MaterniT21 test which analyst Brandon Couillard says is "ramp[ing] at a blistering clip." (Related: Credit Suisse sees robust test volumes)